Advertisement
From 1988 to 2014 there was no change in the overall prevalence of diabetic kidney disease

No Recent Change in Prevalence of Diabetic Kidney Disease

0
No change in overall prevalence from 1988 to 2014; decrease in albuminuria, increase in reduced eGFR
Overall

Many U.S. Hospitals Offer Language Services

0
Percentage of hospitals offering language services increases with level of need
Hydroxycitrate

Hydroxycitrate Promising for Kidney Stone Prevention

0
Researchers suggest it might offer alternative to current treatment that has side effects
For certain patients with metastatic renal cell carcinoma

Active Surveillance Prior to Systemic Tx Feasible in Renal CA

0
Shorter surveillance period for those with more IMDC adverse risk factors, more metastatic disease sites
Since the early 2000s there has been little increase in the prevalence of stage 3 and 4 chronic kidney disease in the United States

No Recent Increase in Prevalence of Chronic Kidney Disease in U.S.

0
Since early 2000s, little increase in prevalence of stage 3 and 4 chronic kidney disease
Tumor cell-intrinsic metabolic factors may contribute to anti-programmed death 1 (PD-1)/PD-L1 treatment resistance in renal cell carcinoma

Metabolic Factors May Contribute to Tx Resistance in Renal Cancer

0
Genes involved in metabolic and solute transport function linked to treatment failure in PD-L1+ RCC
Among adults with septic shock

Vasopressin Doesn’t Cut Kidney Failure-Free Days in Septic Shock

0
No improvement in kidney failure-free days versus norepinephrine in adults with septic shock
Low abundance biomarker panels can predict lupus nephritis outcomes

Urinary Biomarkers Can Predict Response in Lupus Nephritis

0
Models created with traditional + novel biomarkers have clinically meaningful predictive power

July 2016 Briefing – Nephrology

0
Here are what the editors at HealthDay consider to be the most important developments in Nephrology for July 2016. This roundup includes the latest...
European health systems are requiring an increase in cost-sharing measures for patients 50 years of age and older

European Countries Implementing Cost-Sharing

0
Some financial protections are in place for poorer populations